3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Renal Cell
3
Recurrence
2
Neoplasm Metastasis
2
Melanoma
2
Kidney Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymoma
1
Solid Tumors
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Metastatic Urothelial Cancer
1
Interventions
Cisplatin
32
Radiotherapy, Intensity-Modulated
21
Magnetic Resonance Spectroscopy
21
Radiotherapy
16
Specimen Handling
15
Radiation
14
Carboplatin
14
pembrolizumab
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Paclitaxel
8
Chemoradiotherapy
7
Biopsy
7
Taxes
6
Surveys and Questionnaires
6
Cetuximab
6
Nivolumab
5
Surgical Procedures, Operative
4
Observation
4
Fluorodeoxyglucose F18
4
Drug Therapy
4
Docetaxel
4
durvalumab
3
(225)Ac-DOTA-c(RGDyK)
3
toripalimab
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
zimberelimab
×
1 year
×
Clear all
No trials found.